Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study. - Massari F; Rosellini M; Melichar B; Grande E; Bourlon MT; Li H; Fiala O; Park SH; Fita MJJ; Taha T; Molina-Cerrillo J; Santini D; et al. (JCO global oncology, 2025)